Hideki Garren, MD, PhD: Measuring MS Progression With Floodlight Open
The smartphone application-led program, Floodlight Open, recently initiated in the US and Canada.
Hideki Garren, MD, PhD: The ORATORIO-HAND Trial in PPMS
The Global Head of Neuroimmunology at Genentech discussed the upcoming phase III trial of ocrelizumab while on-site at ECTRIMS 2018.
Hideki Garren, MD, PhD: Past and Future Ocrelizumab Analyses
The group medical director of neuroscience at Genentech discussed the history of a well-known therapy for multiple sclerosis: ocrelizumab (Ocrevus).
2 Clarke Drive Cranbury, NJ 08512